Amy McBride Wendell is President & VP at Covidien plc (COV). They have made 16 open-market trades across 5 companies since 2010, most recently 2026-08-11.
CIK 0001400568
7 open-market purchases totalling $868K since 2016, against 9 sales. Across 7 scored buys the stock is up 19.5% at ninety days, and 15.7 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 0% | 71% |
| Avg Move | +1.4% | -5.8% | +19.5% |
| Alpha | +2.3% | -6.6% | +15.7% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AXGN | SELL · 10b5-1 | 2026-08-11 | 2026-08-12 | $48.42 | $647K | +0.6% | -13.7% | — |
| AXGN | SELL | 2026-05-08 | 2026-05-12 | $42.60 | $70K | +0.6% | +4.4% | +18.7% |
| SOLV | BUY | 2026-03-10 | 2026-03-11 | $68.03 | $100K | -2.3% | -2.1% | +22.7% |
| AXGN | SELL | 2025-12-16 | 2025-12-17 | $29.31 | $2.4M | +4.3% | -1.2% | +4.3% |
| AXGN | SELL | 2025-06-09 | 2025-06-11 | $10.61 | $43K | +0.8% | +18.1% | +63.1% |
| AXGN | SELL | 2025-03-03 | 2025-03-05 | $20.02 | $100K | +2.2% | -9.3% | -36.5% |
| AXGN | BUY | 2023-09-06 | 2023-09-08 | $6.22 | $62K | -8.9% | -23.3% | +29.9% |
| AXGN | BUY | 2019-06-13 | 2019-06-14 | $20.25 | $101K | -4.7% | -4.2% | -30.5% |
| AXGN | BUY | 2018-08-14 | 2018-08-16 | $36.89 | $184K | +20.5% | -5.5% | -10.8% |
| HOLX | BUY | 2018-03-14 | 2018-03-16 | $38.43 | $200K | -2.8% | -2.0% | +4.6% |
| EKSO | BUY | 2017-09-14 | 2017-09-15 | $1.23 | $20K | +7.6% | -0.8% | +105.9% |
| AXGN | BUY | 2016-10-07 | 2016-10-14 | $7.50 | $200K | +0.6% | -2.3% | +14.3% |
| COV | SELL · 10b5-1 | 2013-11-26 | 2013-11-27 | $68.00 | $952K | N/A | N/A | N/A |
| COV | SELL · 10b5-1 | 2013-11-14 | 2013-11-15 | $66.00 | $924K | N/A | N/A | N/A |
| COV | SELL | 2013-11-12 | 2013-11-13 | $64.31 | $1.1M | N/A | N/A | N/A |
| COV | SELL | 2013-08-08 | 2013-08-12 | $63.89 | $1.6M | N/A | N/A | N/A |
| COV | SELL · 10b5-1 | 2013-04-02 | 2013-04-04 | $68.00 | $1.2M | N/A | N/A | N/A |
| COV | SELL · 10b5-1 | 2013-03-13 | 2013-03-14 | $66.00 | $990K | N/A | N/A | N/A |
| COV | SELL · 10b5-1 | 2013-03-04 | 2013-03-05 | $64.00 | $960K | N/A | N/A | N/A |
| COV | SELL · 10b5-1 | 2013-01-25 | 2013-01-28 | $63.50 | $953K | N/A | N/A | N/A |
| COV | SELL | 2012-05-04 | 2012-05-04 | $54.45 | $554K | N/A | N/A | N/A |
| COV | SELL | 2011-04-28 | 2011-04-29 | $56.65 | $4.8M | N/A | N/A | N/A |
| COV | SELL | 2010-02-04 | 2010-02-05 | $50.97 | $1.1M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.